Clarapath Reinforces Leadership in Healthcare Robotic Microtomy Systems with Launch of TrimStar Pro™
Clarapath, a leader in healthcare robotic microtomy systems, announced the launch of TrimStar Pro™, a purpose-built facing ...
The Company’s first robotic instrument, called SectionStar™, is a fully automated system which revolutionizes the reliability and efficiency of the pathology lab. The Company’s first robotic ...
WHITE PLAINS, N.Y., March 10, 2026 /PRNewswire/ -- Clarapath, a leader in automated tissue sectioning solutions for anatomic pathology, recently announced the latest release of SectionStar™, the ...
A medical robotics startup in White Plains raised a $36 million Series B-1 funding round led by health care giant Northwell Health last week to automate laboratory processes that diagnose diseases ...
Medical-robotics company Clarapath announced it has secured $36 million in a Series B-1 funding round, bringing its total raise to $75 million. Northwell Ventures led the round, with participation ...
Clarapath, a leader in healthcare robotics, will use the investment to support the commercialization of its platform and fund future laboratory process consolidation Clinical and non-clinical ...
WHITE PLAINS, N.Y., Feb. 27, 2023 /PRNewswire/ -- Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the ...
HAWTHORNE, N.Y., June 22, 2022 (GLOBE NEWSWIRE) -- Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissues, today announced ...
The world of pathology may be welcoming a new robotic co-worker sometime soon. Clarapath Inc, a New York–based biotechnology company, has created an instrument called the SectionStar to automate the ...
The MarketWatch News Department was not involved in the creation of this content. SectionStar is an FDA-registered system designed to enhance consistency, efficiency and quality control in modern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results